Маринов Димитр Тодорович
Russian Cancer Research Center NN Blokhin · 38 works · 34 citations · h-index 3
Top works
- Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
- Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
- STEREOTACTIC RADIOTHERAPY FOR THE TREATMENT OF CLINICAL STAGE I-IIA LUNG CANCER PATIENTS. THE EXPERIENCE OF N.N. BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY
- Eating behavior in patients with breast cancer
- Efficiency integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer and an activating EGFR gene mutation.
- Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
- Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
- Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
- Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers
- Роль лучевой терапии в лечении больных мезотелиомой плевры
- Повторная биопсия у больных немелкоклеточным раком легкого IV стадии после лекарственного лечения
- Phenotypic transformation as a cause of secondary drug resistance to osimetinib clinical observation
- Rebiopsy in IV stage non-small-cell lung cancer patients after systemic therapy
- HIGH-TECH RADIATION THERAPY WITH LOCAL DOSE ESCALATION IN CHEMO-RADIATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER. PREDICTORS OF EFFECTIVENESS
- Modern possibilities of cytological methods in the differential diagnosis of metastatic lesions in mediastinal lymph nodes
- RADIATION THERAPY IN MULTIMODAL TREATMENT OF PATIENTS WITH PLEURAL MESOTHELIOMA. LITERATURE REVIEW AND ANALYSIS OF OWN OBSERVATIONS
- Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer
- Stereotactic hypofractionated radiotherapy for clinical stage I-IIA lung cancer. Predictors for efficacy and toxicity
- Experience of using сrizotinib in patients with ALKpositive non-small cell lung cancer
- Systematic evaluation of intratumoral and peripheral BCR repertoires in three cancers